ACE and cancer: The potential and promise of these compounds are evidenced by breakthroughs such as, angiotensin-converting enzyme (ACE)-inhibitor, Captopril [6] and more recently, ziconotide (Prialt), the first drug from a venomous marine snail, Conus magus, which is used to treat chronic pain in HIV and cancer patients [7].